NCT07110441View on ClinicalTrials.gov

Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 26, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Acute-on-Chronic Liver Failure
Interventions
DRUG

Single Dose G1090N

Subjects will receive single ascending doses of G1090N up to 1200mg.

DRUG

Multiple dosing of G1090N

Subjects will receive multiple ascending doses of G1090N up to 1200mg twice daily for 7 consecutive days.

Trial Locations (1)

92801

RECRUITING

Anaheim Clinical Trials, LLC, Anaheim

Sponsors

Lead Sponsor

Genfit
All Listed Sponsors
lead

Genfit

INDUSTRY

NCT07110441 - Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers | Biotech Hunter | Biotech Hunter